Skip to main content
Contact us

Search and Find the CMO / CDMO You Need for Your Project

Find the expertise you need for your drug development and manufacturing project

Showing 26 facilities
Suggested Results

These facilities match your main criteria but not every optional filter — including other countries in the same region.

Lifecore Injectables CDMO
United States

Lifecore Injectables CDMO

Lifecore Biomedical

CDMO that manufactures clinical & commercial sterile injectable drug products.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Adragos Pharma | Halden
Norway

Adragos Pharma | Halden

Adragos Pharma

We specialize in the manufacturing of IV bags, plastic ampoules and vials using Blow-Fill-Seal (BFS) technology and other dosage forms.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), TGA (Australia)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

BATCH SIZE: Large, Small, Medium

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (V06) Nutrients, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Cenexi Hérouville Saint Clair
France

Cenexi Hérouville Saint Clair

Cenexi

The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquids.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human

SERVICES: Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (N) Nervous system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

CDM Lavoisier is specialized in the manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

We can take your pharmaceuticals from lab scale to the early clinical phase and beyond.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

A GMP facility fully equipped for R&D and pharmaceutical development. Includes laboratories and a pilot plant for technical and clinical batches.

Location available after registration

Limited view

COSMETICS manufacturing site

MAI network supplier

Production facility that complies with the latest GMP standards for sterile and aseptic liquids, particularly glass ampoules.

Location available after registration

Limited view

SERVICES manufacturing site

MAI network supplier

The site specializes in the development and production of solid and liquid pharmaceutical forms, both sterile and non-sterile.

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Dry Powder Inhalation Plant.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Contract research and development laboratory (CRDO) based in USA that provides pharmaceutical product development services.

Location available after registration

Limited view

COSMETICS manufacturing site

MAI network supplier

SUPPLIER OF PATCHES, ORAL FILMS, HYDROGELS AND WET WIPES

Location available after registration

Limited view

SERVICES manufacturing site

MAI network supplier

Sterile fill-finish manufacturing site for injectable drug products (vials, ampoules, lyophilized).

Location available after registration

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+15 more facilities

Create free account

Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.

Why Choose MAI CDMO Network?

  • Comprehensive Provider Directory: Discover a diverse range of CMOs and CDMOs specializing in various services, including API manufacturing, clinical trial supplies, fill-finish, packaging, and more.
  • Tailored Search Capabilities: Our advanced search filters allow you to refine your search based on specific criteria such as location, capabilities, capacity, and regulatory compliance.
  • Global Reach: Connect with CMOs and CDMOs from around the world to find the perfect partner for your global projects.
  • Time and Cost Savings: Streamline your sourcing process and reduce time-to-market by finding the right partner on our platform.
  • Enhanced Decision Making: Access detailed company profiles, case studies, and reviews to make informed decisions.

How MAI CDMO Network Works

  • Create a Free Account: Sign up for a free account to access our extensive database of CMOs and CDMOs.
  • Refine Your Search: Use our advanced search filters to identify providers that meet your exact requirements.
  • Request Quotes: Contact selected providers directly to request quotes and learn more about their services.
  • Make Informed Decisions: Compare quotes, review company profiles, and select the best partner for your project.

Key Benefits of Partnering with a CMO/CDMO

  • Accelerated Time-to-Market: Leverage the expertise and resources of a CMO/CDMO to expedite your drug development process.
  • Reduced Costs: Benefit from economies of scale and specialized equipment to reduce manufacturing costs.
  • Improved Quality: Ensure product quality and compliance with regulatory standards through rigorous quality management systems.
  • Increased Flexibility: Scale up or down production as needed to meet changing market demands.
  • Focus on Core Competencies: Outsource non-core activities to free up internal resources for innovation and strategic initiatives.

Featured Services

  • API Manufacturing: Source high-quality active pharmaceutical ingredients from experienced manufacturers.
  • Clinical Trial Supplies: Secure reliable and compliant supplies for your clinical trials.
  • Fill-Finish and Packaging: Partner with experts in sterile filling, lyophilization, and packaging to ensure product stability and patient safety.
  • Analytical Testing: Access a wide range of analytical services to support your drug development program.

Ready to Find Your Ideal CMO/CDMO Partner? Register Now

Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.